Recent studies have shown an aggressive increase in the utilization of oxygen among COPD patients. With this increase of over 15% in just a few years alongside the growth of other disease states the home oxygen market is undergoing rapid expansion.

Riverside Medical is poised to effectively serve this expanding market through both current geographical distribution alongside a large team of respiratory therapists trained to help reduce re-admissions from disease state complications. Easy access and higher quality results are a keystone of Riverside Medical’s philosophy.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364693/